Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
7.17
+0.04 (0.56%)
At close: Dec 31, 2025, 4:00 PM EST
7.14
-0.04 (-0.49%)
After-hours: Dec 31, 2025, 7:59 PM EST
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $1.86 billion as of December 31, 2025. Its market cap has decreased by -52.69% in one year.
Market Cap
1.86B
Enterprise Value
10.02B
1-Year Change
-52.69%
Ranking
Category
Stock Price
$7.17
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $1.86B, a decrease of -77.85%. That is a compound annual growth rate of -27.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.91B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.80B |